NEU 3.32% $20.52 neuren pharmaceuticals limited

Ann: Notification under Listing Rule 7.20 of share reorganisation, page-173

  1. GC8
    1,890 Posts.
    lightbulb Created with Sketch. 3
    So a deal is pending.....typically such deals involve upfront payments. So why on earth is it necessary for a share arrangement with Lanstead Capital especially with the majority of the funds drip fed to NEU over 18 months?
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.